Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. specializes in in-vitro diagnostic (IVD) devices, specifically kits designed to detect human chorionic gonadotropin (hCG) in clinical settings. Their products include rapid immunochromatographic tests (ICT) and digital versions, such as the e.p.t. Early Pregnancy Test and its digital counterpart, which are used for early pregnancy confirmation in healthcare environments.

Prestige Consumer Healthcare Inc. is based in the United States, which means its devices are regulated under the US Food and Drug Administration (FDA) framework. Since the company’s products are designed for clinical use in the US, they fall under FDA oversight, including classification and listing requirements like the UDI database.

Prestige Consumer Healthcare Inc.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and transparency of medical devices under FDA jurisdiction, helping healthcare providers and regulators identify and verify the products in clinical use.

The company’s hCG detection kits, such as the e.p.t. Early Pregnancy Test, are classified as Class II devices under the US regulatory system. This classification applies to devices that pose moderate risk and require special controls to ensure their safety and effectiveness, such as performance standards or post-market surveillance.